The Correlation of Age with Prognosis of Atypia of Undetermined Significance and Follicular Lesion of Undetermined Significance in Thyroid Nodules

References

• Kaliszewski K , Diakowska D , Wojtczak B , Rudnicki J , Schmitt F . Cancer screening activity results in overdiagnosis and overtreatment of papillary thyroid cancer: a 10-year experience at a single institution. PLoS One . 2020;15(7):e0236257. doi:10.1371/journal.pone.0236257 32692768
   PubMed Web of Science ®Google Scholar
• Cibas ES , Ali SZ . The bethesda system for reporting thyroid cytopathology. Am J Clin Pathol . 2009;132(5):658–665.19846805
   PubMed Web of Science ®Google Scholar
• Cibas ES , Ali SZ . The 2017 bethesda system for reporting thyroid cytopathology. J Am Soc Cytopathol . 2017;6(6):217–222.31043290
   PubMedGoogle Scholar
• Krane JF , Nayar R , Renshaw AA . Atypia of undetermined significance/follicular lesion of undetermined significance. In: Ali SZ , Cibas ES , editors. The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes . 2nd ed. Switzerland: Springer Nature; 2018:49–70.
   Google Scholar
• Huhtamella R , Kholová I . Thyroid bethesda category AUS/FLUS in our microscopes: three-year-experience and cyto-histological correlation. Cancers (Basel) . 2019;11(11):1670.
   PubMed Web of Science ®Google Scholar
• Almahari SA , Harb Z , Alshaikh S . Evaluation of thyroid nodules classified as Bethesda category III on cytology and their malignancy rate: an institutional experience. Cytojournal . 2019;16:18.31576199
   PubMed Web of Science ®Google Scholar
• Pasha HA , Dhanani R , Mughal A , Ahmed KS , Suhail A . Malignancy rate in thyroid nodules with atypia or follicular lesion of undetermined significance. Int Arch Otorhinolaryngol . 2020;24(2):e221–e226.32256845
   PubMed Web of Science ®Google Scholar
• Seagrove-Guffey MA , Hatic H , Peng H , Bates KC , Odugbesan AO . Malignancy rate of atypia of undetermined significance/follicular lesion of undetermined significance in thyroid nodules undergoing FNA in a suburban endocrinology practice: a retrospective cohort analysis. Cancer Cytopathol . 2018;126(10):881–888.30335212
   PubMed Web of Science ®Google Scholar
• Vázquez YL , Penín Álvarez M , San Miguel Fraile P , Barragáns Pérez M . Riesgo de malignidad de los nodulos tiroideos con atypia de significado incierto. Endocrinol Nutr . 2015;62(10):507–510.26526719
   PubMedGoogle Scholar
• Ling J , Li W , Lalwani N . Atypia of undetermined significance/follicular lesions of undetermined significance: what radiologists need to know. Neuroradiol J . 2020. doi:10.1177/1971400920983566
   Web of Science ®Google Scholar
• Cibas ES , Ali SZ . The 2017 bethesda system for reporting thyroid cytopathology. Thyroid . 2017;27(11):1341–1346.29091573
   PubMed Web of Science ®Google Scholar
• Valderrabano P , Khazai L , Thompson ZJ , et al. Cancer risk associated with nuclear atypia in cytologically indeterminate thyroid nodules: a systematic review and meta-analysis. Thyroid . 2018;28(2):210–219.29160163
   PubMed Web of Science ®Google Scholar
• Kaliszewski K , Diakowska D , Wojtczak B , Forkasiewicz Z . Evaluation of selected ultrasound features of thyroid nodules with atypia of undetermined significance/follicular lesion of undetermined significance for the Bethesda reporting system for thyroid cytology. Cancer Manag Res . 2018;10:2223–2229.30087580
   PubMed Web of Science ®Google Scholar
• Garg S , Naik LP , Kothari KS , Fernandes GC , Agnihotri MA , Gokhale JC . Evaluation of thyroid nodules classified as Bethesda category III on FNAC. J Cytol . 2017;34(1):5–9.28182068
   PubMed Web of Science ®Google Scholar
• Sullivan PS , Hirschowitz SL , Fung PC , Apple SK . The impact of atypia/follicular lesion of undetermined significance and repeat fine-needle aspiration: 5 years before and after implementation of the Bethesda System. Cancer Cytopathol . 2014;122(12):866–872.25078420
   PubMed Web of Science ®Google Scholar
• Ho AS , Sarti EE , Jain KS , et al. Malignancy rate in thyroid nodules classified as Bethesda category III (AUS/FLUS). Thyroid . 2014;24(5):832–839.24341462
   PubMed Web of Science ®Google Scholar
• Perrier ND , Brierley JD , Tuttle RM . Differentiated and anaplastic thyroid carcinoma: major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin . 2018;68(1):55–63.29092098
   PubMed Web of Science ®Google Scholar
• Ali SZ , Cibas ES . The Bethesda System for Reporting Thyroid Cytopathology: Definitions, Criteria, and Explanatory Notes . Springer: Cham, Switzerland; 2018.
   Google Scholar
• Kumbhar SS , O’Malley RB , Robinson TJ , et al. Why thyroid surgeons are frustrated with radiologists: lessons learned from pre- and postoperative US. Radiographics . 2016;36(7):2141–2153.27768542
   PubMed Web of Science ®Google Scholar
• Tessler FN , Middleton WD , Grant EG , et al. ACR thyroid imaging, reporting and data system (TI-RADS): white paper of the ACR TI-RADS committee. J Am Coll Radiol . 2017;14(5):587–595.28372962
   PubMed Web of Science ®Google Scholar
• Haugen BR , Alexander EK , Bible KC , et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid . 2016;26(1):1–133.26462967
   PubMed Web of Science ®Google Scholar
• Jing X , Michael CW . Potential pitfalls for false suspicion of papillary thyroid carcinoma: a cytohistologic review of 22 cases. Diagn Cytopathol . 2012;40(Suppl 1):E74–E79.21563322
   PubMed Web of Science ®Google Scholar
• Baloch ZW , LiVolsi VA . Cytologic and architectural mimics of papillary thyroid carcinoma. Diagnostic challenges in fine-needle aspiration and surgical pathology specimens. Am J Clin Pathol . 2006;125(Suppl):S135–S144.16830963
   PubMedGoogle Scholar
• Straccia P , Rossi ED , Bizzarro T , et al. A meta-analytic review of the bethesda system for reporting thyroid cytopathology: has the rate of malignancy in indeterminate lesions been underestimated? Cancer Cytopathol . 2015;123(12):713–722.26355876
   PubMed Web of Science ®Google Scholar
• Somma J , Schlecht NF , Fink D , Khader SN , Smith RV , Cajigas A . Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol . 2010;54(2):123–131.20391966
   PubMed Web of Science ®Google Scholar
• Shi Y , Ding X , Klein M , et al. Thyroid fine‐needle aspiration with atypia of undetermined significance: a necessary or optional category? Cancer Cytopathol . 2009;117(5):298–304.
   PubMed Web of Science ®Google Scholar
• Liu X , Medici M , Kwong N , et al. Bethesda categorization of thyroid nodule cytology and prediction of thyroid cancer type and prognosis. Thyroid . 2016;26(2):256–261.26563459
   PubMed Web of Science ®Google Scholar
• Evranos B , Polat SB , Baser H , et al. Bethesda classification is a valuable guide for fine needle aspiration reports and highly predictive especially for diagnosing aggressive variants of papillary thyroid carcinoma. Cytopathology . 2017;28(4):259–267.27666595
   PubMed Web of Science ®Google Scholar
• Guleria P , Agarwal S , Iyer VK , Jain D , Mathur SR , Yadav D . Subcategorisation of AUS/FLUS thyroid lesions as per the 2017 Bethesda System for Reporting Thyroid Cytopathology: a retrospective study from a tertiary care centre analysing risk of malignancy (ROM) of the different subcategories. J Clin Pathol . 2019;72(11):771–777.31375535
   PubMed Web of Science ®Google Scholar
• Gweon HM , Son EJ , Youk JH , Kim JA . Thyroid nodules with Bethesda system III cytology: can ultrasonography guide the next step? Ann Surg Oncol . 2013;20(9):3083–3088.23700214
   PubMed Web of Science ®Google Scholar
• Yoo WS , Choi HS , Cho SW , et al. The role of ultrasound findings in the management of thyroid nodules with atypia or follicular lesions of undetermined significance. Clin Endocrinol (Oxf) . 2014;80(5):735–742.24117478
   PubMed Web of Science ®Google Scholar
• Kuru B , Atmaca A , Tarim IA , et al. Risk factors associated with malignancy and with triage to surgery in thyroid nodules classified as Bethesda category III (AUS/FLUS). Eur J Surg Oncol . 2016;42(1):87–93.26527545
   PubMed Web of Science ®Google Scholar
• Lee S , Shin JH , Oh YL , Hahn SY . Subcategorization of Bethesda system category III by Ultrasonography. Thyroid . 2016;26(6):836–842.27094511
   PubMed Web of Science ®Google Scholar
• Amin MB , Greene FL , Edge SB , et al. The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more “personalized” approach to cancer staging. CA Cancer J Clin . 2017;67(2):93–99.28094848
   PubMed Web of Science ®Google Scholar
• Kaliszewski K , Diakowska D , Nowak Ł , Wojtczak B , Rudnicki J . The age threshold of the 8th edition AJCC classification is useful for indicating patients with aggressive papillary thyroid cancer in clinical practice. BMC Cancer . 2020;20(1):1166.33256657
   PubMed Web of Science ®Google Scholar
• Williams BA , Bullock MJ , Trites JR , Taylor SM , Hart RD . Rates of thyroid malignancy by FNA diagnostic category. J Otolaryngol Head Neck Surg . 2013;42(1):61.24359603
   PubMed Web of Science ®Google Scholar
• Hong IK , Kim JH , Cho YU , Park SY , Kim SJ . Clinicopathological factors increased the risk of malignancy in thyroid nodules with atypical or follicular lesions of undetermined significance (AUS/FLUS) risk factor of malignancy in thyroid nodule with AUS/FLUS. Ann Surg Treat Res . 2016;90(4):201–206.27073790
   PubMed Web of Science ®Google Scholar
• Mulder MB , Khazeni KC , Sussman MS , Lew JI , Farrá JC . Chronic lymphocytic thyroiditis may lower accuracy of AUS/FLUS cytopathology in surgical patients. J Surg Res . 2020;245:244–248.31421369
   PubMed Web of Science ®Google Scholar
• Luu MH , Fischer AH , Stockl TJ , Pisharodi L , Owens CL . Atypical follicular cells with equivocal features of papillary thyroid carcinoma is not a low-risk cytologic diagnosis. Acta Cytol . 2011;55(6):526–530.22156461
   PubMed Web of Science ®Google Scholar
• Kim SJ , Roh J , Baek JH , et al. Risk of malignancy according to sub-classification of the atypia of undetermined significance or follicular lesion of undetermined significance (AUS/FLUS) category in the Bethesda system for reporting thyroid cytopathology. Cytopathology . 2017;28(1):65–73.27245883
   PubMed Web of Science ®Google Scholar
• Eisa N , Khan A , Akhter M , et al. Both ultrasound features and nuclear atypia are associated with malignancy in thyroid nodules with atypia of undetermined significance. Ann Surg Oncol . 2018;25(13):3913–3918.30302643
   PubMed Web of Science ®Google Scholar
• Seo JW , Jang AL , Suh SH , Park HS , Kang MK , Hong JC . Atypia of undetermined significance on thyroid fine needle aspiration – risk factors for malignancy. Clin Otolaryngol . 2017;42(2):234–238.27383045
   PubMed Web of Science ®Google Scholar
• Estrada Muñoz L , Díaz Del Arco C , Ortega Medina L , Fernández Aceñero MJ . Thyroid atypia/follicular lesion of undetermined significance: attitudes towards the diagnosis of bethesda system III nodules. Acta Cytol . 2017;61(1):21–26.27852075
   PubMed Web of Science ®Google Scholar
• Steward D , Carty S , Sippel R , Yang P , Sosa J , Sipos J. Clinical validation of ThyroSeq v3 performance in thyroid nodules with indeterminate cytology: a prospective blinded multi-institutional validation study. In: Short Call Oral Abstract #5. Victoria, BC, Canada: 87th Annual Meeting of the American Thyroid Association; 2017.
   Google Scholar